Skip to content

Electra Therapeutics, Inc.

ETRA· Nasdaqxbrl foundCIK 2088082

Biological products, except diagnostic substances175 peers

Last sale
Nov 12, 2026 · -3.18%
Market cap
$574.60M
62.87M shares
Filings
41
$0.00
Q3 2026
—
-$23.93M
Q3 2026
—
-$25.06M
Q3 2026
—
—
—
—
-$3.47
Q3 2026
—
$256.41M
Q3 2026
—
$574.60M
—
—
1.5×
—
—

FY2026 figures · derived

Price

$9.1431.02%$4.11since Sep 18, 2026
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$0.00Q3 2026
No annual history for this metric yet.
PeriodEndedValueKindSource trail

Biological products, except diagnostic substances

Electra Therapeutics, Inc. is the 61st largest of the 176 covered companies the SEC files under this code, by market cap. SIC 2836

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Electra Therapeutics, Inc. · CIK 2088082 · Engraved from SEC EDGAR